4-chlorokynurenine
4-Chlorokynurenine (also known as AV-101 or L-4-chlorokynurenine) is a prodrug that is converted into 7-chlorokynurenic acid (7-Cl-KYNA), an antagonist of the N-methyl-D-aspartate receptor (NMDAR), in the brain. It is being developed as a potential treatment for various neurological and psychiatric disorders.
Chemistry[edit | edit source]
4-Chlorokynurenine is a chlorinated derivative of kynurenine, an intermediate in the kynurenine pathway of tryptophan metabolism. It is a prodrug for 7-chlorokynurenic acid, a potent and selective antagonist of the glycine site of the NMDAR.
Pharmacology[edit | edit source]
After oral administration, 4-chlorokynurenine crosses the blood-brain barrier and is converted into 7-Cl-KYNA by astrocytes. 7-Cl-KYNA is a potent and selective antagonist of the glycine site of the NMDAR, which is implicated in the pathophysiology of several neurological and psychiatric disorders.
Clinical development[edit | edit source]
4-Chlorokynurenine is being developed as a potential treatment for several conditions, including major depressive disorder, neuropathic pain, epilepsy, schizophrenia, and Parkinson's disease. It is currently in clinical trials.
See also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD